论文信息 - Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial - 字舞流文

Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial

J. Doroshow | D. Gandara | H. Lenz | A. Colevas | D. Quinn | M. Lewis | J. Longmate | T. Synold | R. Morgan | B. Xi | M. D. Lewis | E. Newman | C. Ruel | M. Lewis | A. Dimitrios Colevas | Robert J. Morgan | Jeffrey Longmate | David I. Quinn | Michael D. Lewis